Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Allie Garfinkle

Abridge CEO Shiv Rao on raising $300 million, a prospective IPO, and the future of healthcare

Shiv Rao (Credit: Stuart Isett for Fortune)

Shiv Rao has always been really clear with me about what the best thing about being a doctor is. 

In February, when I profiled Rao—CEO and cofounder of Abridge, and a practicing cardiologist—he told me that it was growing old with your patients, living a full life together. Rao himself has multiple lives, still showing up to take on clinical shifts and building Abridge, a healthcare AI startup that’s made its name in medical transcription. We catch up because Abridge is barreling towards its future rapidly—the company just raised a $300 million Series E led by Andreessen Horowitz, with participation from Khosla Ventures. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.